A macrophage-specific synthetic promoter for therapeutic application of adiponectin.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 1, doi. 10.1038/gt.2014.3
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2014 AND VI 21 AND IP 2
Results: 15
1
2
Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 131, doi. 10.1038/gt.2013.63
- By:
- Publication type:
- Article
3
Modulation of T<sub>reg</sub> function improves adenovirus vector-mediated gene expression in the airway.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 219, doi. 10.1038/gt.2013.78
- By:
- Publication type:
- Article
4
Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 148, doi. 10.1038/gt.2013.67
- By:
- Publication type:
- Article
5
shRNA-induced saturation of the microRNA pathway in the rat brain.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 205, doi. 10.1038/gt.2013.76
- By:
- Publication type:
- Article
6
Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-Diethylaminoethyl-Dextran Methyl Methacrylate Copolymer Non-Viral Vector-p53.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 158, doi. 10.1038/gt.2013.68
- By:
- Publication type:
- Article
7
The effect of helper epitopes and cellular localization of an antigen on the outcome of gene gun DNA immunization.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 225, doi. 10.1038/gt.2013.81
- By:
- Publication type:
- Article
8
Design of magnetic polyplexes taken up efficiently by dendritic cell for enhanced DNA vaccine delivery.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 212, doi. 10.1038/gt.2013.77
- By:
- Publication type:
- Article
9
A novel gene therapy strategy using secreted multifunctional anti-HIV proteins to confer protection to gene-modified and unmodified target cells.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 175, doi. 10.1038/gt.2013.70
- By:
- Publication type:
- Article
10
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 195, doi. 10.1038/gt.2013.73
- By:
- Publication type:
- Article
11
In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 168, doi. 10.1038/gt.2013.69
- By:
- Publication type:
- Article
12
Quantitative morphological comparison of axon-targeting strategies for gene therapies directed to the nigro-striatal projection.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 115, doi. 10.1038/gt.2013.74
- By:
- Publication type:
- Article
13
A novel gene delivery method transduces porcine pancreatic duct epithelial cells.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 123, doi. 10.1038/gt.2013.62
- By:
- Publication type:
- Article
14
Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 188, doi. 10.1038/gt.2013.72
- By:
- Publication type:
- Article
15
Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair.
- Published in:
- Gene Therapy, 2014, v. 21, n. 2, p. 139, doi. 10.1038/gt.2013.66
- By:
- Publication type:
- Article